Document is current
Any future updates will be listed below
-
Authors
White, Owen A. https://orcid.org/0000-0002-1411-6667
Shur, Joshua https://orcid.org/0000-0002-4569-4785
Castagnoli, Francesca https://orcid.org/0000-0003-2407-7451
Charles-Edwards, Geoff https://orcid.org/0000-0002-8369-4604
Whitcher, Brandon https://orcid.org/0000-0002-6452-2399
Collins, David J. https://orcid.org/0000-0001-8281-1496
Cashmore, Matthew T. D. https://orcid.org/0000-0003-0098-0742
Hall, Matt G. https://orcid.org/0000-0002-9530-5477
Thomas, Spencer A. https://orcid.org/0000-0002-9260-1561
Thompson, Andrew https://orcid.org/0000-0002-4580-0357
Harrison, Ciara A. https://orcid.org/0009-0005-6229-9030
Hopkinson, Georgina https://orcid.org/0000-0003-4967-8886
Koh, Dow-Mu https://orcid.org/0000-0001-7654-8011
Winfield, Jessica M. https://orcid.org/0000-0001-6069-5252
-
Funding
Funding for this research was provided by:
Cancer Research UK (National cancer Imaging Trials Accelerator (NCITA))
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
UK Government’s Department for Science, Innovation & Technology (National Measurement System (NMS) programmes)
- License Information
-
More Information
Article History
Received: 30 September 2024
Revised: 14 March 2025
Accepted: 7 April 2025
First Online: 24 May 2025
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article. This was a prospective, single-centre study approved by a national research ethics committee (ClinicalTrials.gov Identifier: NCT05118555). Verbal consent was obtained from all the patients for additional imaging as part of routine clinical examinations.
